期刊文献+

滑膜间充质干细胞关节腔内注射治疗关节软骨损伤 被引量:2

Intra-articular injection of synovial mesenchymal stem cells to treat articular cartilage injury
下载PDF
导出
摘要 背景:研究显示,在众多的种子细胞中滑膜间充质干细胞对关节软骨损伤再生修复具有许多独特的优势。目的:对滑膜间充质干细胞的研究进展及其关节腔内注射治疗关节软骨损伤的应用进行综述。方法:第一作者通过计算机检索Pub Med和CNKI数据库2004年1月至2014年12月的相关文献,检索关键词为"滑膜间充质干细胞、注射治疗、软骨修复;Synovial mesenchymal stem cells;Intra-articular injection;Cartilage repair",纳入57篇文献进行分析。结果与结论:滑膜间充质干细胞分离培养方法简便,在软骨损伤修复方面具有很大的优势,通过将其注射于关节腔内治疗关节软骨损伤具有一定的可行性和安全性,作为一种潜在的治疗方式,有望给软骨损伤患者带来曙光,但仍然存在诸多问题,还需要进一步深入研究。 BACKGROUND: Among various seed cells, synovial mesenchymal stem cells have unique advantages in the repair of articular cartilage injury. OBJECTIVE: To review the progress of synovial mesenchymal stem cells and its intra-articular injection in the treatment of articular cartilage injury. METHODS: The first author searched Pub Med and CNKI by computer to retrieve articles published from January 2004 to December 2004 using the keywords of "synovial mesenchymal stem cells; intra-articular injection; cartilage repair" in English and Chinese, respectively. Finally, 57 articles were included in result analysis. RESULTS AND CONCLUSION: It is easy to isolate and culture synovial mesenchymal stem cells, which has great advantages in cartilage repair. What's more, intra-articular injection therapy for articular cartilage injury is feasible and safe. Intra-articular injection of synovial mesenchymal stem cells is a very promising treatment for cartilage damage, but there are still many problems to be solved in the future.
出处 《中国组织工程研究》 CAS 北大核心 2015年第36期5892-5897,共6页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金(30801159) 博士后科研基金(20110491841) 首都医学发展科研基金(39770714)~~
关键词 干细胞 移植 滑膜间充质干细胞 注射治疗 软骨修复 国家自然科学基金 Synovial Membrane Mesenchymal Stem Cells Cartilage Diseases
  • 相关文献

参考文献51

  • 1Berninger MT, Wexel G, Rummeny E J, et al. Treatment of osteochondral defects in the rabbit's knee joint by implantation of allogeneic mesenchymal stem cells in fibrin clots. J Vis Exp. 2013;(75):e4423.
  • 2Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 2007;327(3):449-462.
  • 3Sakaguchi Y, Sekiya I, Yagishita K, et al. Comparison of human stem cells derived from various mesenchymal tissues superiority of synovium as a cell source. Arthritis Rheum. 2005;52(8):2521-2529.
  • 4Koga H, Muneta T, Nagase T, et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res. 2008;333(2): 207-215.
  • 5Lee DH, Joo SD, Han SB, et ai. Isolation and expansion of synovial CD34(-)CD44(+)CD90(+) mesenchymal stem cells: comparison of an enzymatic method and a direct explant technique, onnect Tissue Res. 2011;52(3):226-234.
  • 6Gerecht-Nir S, Cohen S, Itskovitz-EIdor J. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng. 2004; 86(5): 493-502.
  • 7Park Y, Sugimoto M, Watrin A, et al. BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three- dimensional alginate hydrogel. Osteoarthritis Cartilage. 2005;13(6):527-536.
  • 8Farrell M J, Shin JI, Smith L J, et al. Functional consequences of glucose and oxygen deprivation on engineered mesenchymal stem cell-based cartilage constructs. Osteoarthritis Cartilage. 2015;23(1 ): 134-142.
  • 9Pei M, He F, Li J, et al. Repair of large animal partial-thickness cartilage defects through intraarticular injection of matrix-rejuvenated synovium-derived stem cells Tissue Eng Part A. 2013;19(9-10):1144-1154.
  • 10Santhagunam A, Dos Santos F, Madeira C, et al. Isolation and ex vivo expansion of synovial mesenchymal stromal cells for cartilage repair. Cytotherapy. 2014;16(4):440-453.

二级参考文献117

  • 1宁红梅,金建刚,扈江伟,冯凯,陈虎.人骨髓间充质干细胞体外对异基因T淋巴细胞表型的影响[J].中国实验血液学杂志,2005,13(1):43-49. 被引量:22
  • 2[1]Buckwalter JA,Lohmander S. Operative treatment of osteoarthrosis. Current practice and future development. J Bone Joint Surg(Am),1994;76(9):1 405
  • 3[2]Gillogly SD,Voight M,Blackburn T. Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation. J Orthop Sports Phys Ther, 1998;28(4):241
  • 4[3]Hunziker EB,Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg (Am), 1996;78(5):721
  • 5[4]Quintavalla J, Uziel-Fusi S,Yin J,et al. Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials, 2002;23(1):109
  • 6[5]Hiraki Y, Shukunami C, Iyama K,et al. Differentiation of chondrogenic precursor cells during the regeneration of articular cartilage. Osteoarthritis Cartilage, 2001;9 Suppl A:S102
  • 7[6]Frisbie DD,Oxford JT,Southwood L,et al. Early events in cartilage repair after subchondral bone microfracture. Clin Orthop, 2003;(407):215
  • 8[7]Huang Q, Goh JC, Hutmacher DW, et al.In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor beta1 and the potential for in situ chondrogenesis. Tissue Eng,2002;8(3):469
  • 9[8]Hunziker EB. Growth-factor-induced healing of partial-thickness defects in adult articular cartilage. Osteoarthritis Cartilage, 2001;9(1):22
  • 10[9]Hunziker EB, Kapfinger E. Removal of proteoglycans from the surface of defects in articular cartilage transiently enhances coverage by repair cells. J Bone Joint Surg Br, 1998;80(1):144

共引文献33

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部